Amadeus a division of Xybion  

Amadeus Press Releases

 

Victhom selects eQCM® to automate all its quality and compliance processes

Quebec City, July 29, 2008 – Amadeus, a division of Xybion, a company specialized in business solutions and professional services in corporate performance, quality and compliance management software solutions, today announced that Victhom Human Bionics inc., « Victhom » (TSX : VHB) has selected the complete Amadeus platform eQCM® to automate all its quality and compliance processes.

The operational unit Neurobionix of Victhom, dedicated to the neuromodulation, will use the powerful and user-friendly Amadeus solution to meet the more and more demanding quality and compliance requirements that it has to comply with. The selection of eQCM® software will enable Neurobionix to work in a transparent and robust environment and will have a significant synergistic impact within the organization.

Functionalities of the solution and its user-friendliness have rapidly convinced Victhom’s management of the relevance of selecting the Amadeus solution. Statistics and reports that users will be able to access will enable them to accurately and automatically measure and assess the performance of a process and the trends; this made a significant difference. The performance indicators will foster the efforts related to continuous improvement while minimizing potential risks within the organization.

Mr. Nader Kameli, Chief Operating Officer of the Neurobionix business unit at Victhom said that the proximity of the company, the approach and flexibility of Amadeus’ platform favored the selection. He carried on and mentioned that Victhom is very excited to establish strong relationships with a firm from Quebec City to follow through its regulatory compliance and quality objectives.

Amadeus is  especially proud to include Victhom among its new customers, a company from Quebec City that aims for years for high-performance and innovative solutions in human bionics to compensate for biomechanical dysfunctions’’, said Pierre-François Isabel, Vice-President of Amadeus, a division of Xybion. “To become the global standard in this sector inevitably requires working with competitive tools: a flexible and robust software that assures traceability and compliance intelligence, it’s exactly what the third generation of our platform delivers, ’’ he said.

About Victhom

Victhom discovers, develops and manufactures bionic devices involved in the treatment of a variety of physical and physiological dysfunctions. Victhom’s Neurobionix business unit focuses on the development and commercialization of technologies and products involving implantable devices that feature neurosensing and neurostimulation components, integrated with artificial intelligence. Victhom’s Biotronix business unit develops biomechatronic products to support or replace peripheral limbs in what is known as the orthotics and prosthetics market.
 
About Amadeus

Amadeus, a division of Xybion, is a leading provider of Enterprise Quality and Compliance Management software solutions.  For over 14 years, customers in the Life Sciences, Manufacturing, Financial Services and other industries have automated their compliance and quality processes using Amadeus software platforms. Its flagship product, eQCM®, offers an integrated and very cost effective solution for enterprise governance, risk management, quality and compliance management. Amadeus’s solutions have been implemented in more than 100 companies in North America and Europe. (www.amadeussolutions.com)

- 30 -

For further information:

Isabelle Rivoal
Communications Director
Amadeus, a division of Xybion
Phone: +1 (418) 525-0606, ext. 2231

E-mail: isabelle.rivoal@amadeussolutions.com




Xybion    Copyright © 2010 Amadeus, a division of